Reducing Bureaucracy in Clinical Research: A Call for Action
Open Access
- 26 February 2020
- journal article
- editorial
- Published by Wiley in HemaSphere
- Vol. 4 (2), e352
- https://doi.org/10.1097/hs9.0000000000000352
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Is Good Clinical Practice Becoming Poor Clinical Care?HemaSphere, 2017
- Audits and InspectionsPublished by Elsevier BV ,2017
- Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium GuidanceDrug Safety, 2013
- Use of Patient-Reported Outcomes to Improve the Predictive Accuracy of Clinician-Reported Adverse EventsJNCI Journal of the National Cancer Institute, 2011
- Readability and Comprehensibility of Informed Consent Forms for Clinical Trials2010
- The Missing Voice of Patients in Drug-Safety ReportingThe New England Journal of Medicine, 2010
- Re-consenting human subjects: ethical, legal and practical issuesJournal of Medical Ethics, 2009
- Agreement between patient-reported symptoms and their documentation in the medical record.2008
- The impact of the ‘Clinical Trials’ directive on the cost and conduct of non-commercial cancer trials in the UKEuropean Journal of Cancer, 2007
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.2005